Hematopoietic stem cell transplantation (HSCT) in the COVID-19 pandemic era

Hematopoietic stem cell transplantation (HSCT) in the COVID-19 pandemic era

Abstract The pandemic of coronavirus infectious disease-2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a threat to global health. This has become an obstacle for the practice of hematology, mostly in low-middle income countries. For those hematologist and oncologists who perform hematopoietic stem cell transplantation HSCT the usual challenges of this kind of medical procedures have increased because of the COVID-19 pandemic. The importance of find the best route for performing HSCT avoiding excessive COVID-19 risk is of great importance. By doing so, we have been able to conduct 170 hematopoieic stem cell transplants during the COVID-19 pandemia.

Saved in:
Bibliographic Details
Main Authors: Gómez-Almaguer,David, Herrera-Rojas,Miguel, Olivares-Gazca,Juan Carlos, Ruiz-Argüelles,Guillermo J.
Format: Digital revista
Language:English
Published: Academia Nacional de Medicina de México A.C. 2021
Online Access:http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0016-38132021000900020
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0016-38132021000900020
record_format ojs
spelling oai:scielo:S0016-381320210009000202022-04-25Hematopoietic stem cell transplantation (HSCT) in the COVID-19 pandemic eraGómez-Almaguer,DavidHerrera-Rojas,MiguelOlivares-Gazca,Juan CarlosRuiz-Argüelles,Guillermo J. COVID-19 SARS-CoV-2 Stem cell Transplants Transplantation Abstract The pandemic of coronavirus infectious disease-2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a threat to global health. This has become an obstacle for the practice of hematology, mostly in low-middle income countries. For those hematologist and oncologists who perform hematopoietic stem cell transplantation HSCT the usual challenges of this kind of medical procedures have increased because of the COVID-19 pandemic. The importance of find the best route for performing HSCT avoiding excessive COVID-19 risk is of great importance. By doing so, we have been able to conduct 170 hematopoieic stem cell transplants during the COVID-19 pandemia.info:eu-repo/semantics/openAccessAcademia Nacional de Medicina de México A.C.Gaceta médica de México v.157 suppl.3 20212021-01-01info:eu-repo/semantics/reporttext/htmlhttp://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0016-38132021000900020en10.24875/gmm.m21000473
institution SCIELO
collection OJS
country México
countrycode MX
component Revista
access En linea
databasecode rev-scielo-mx
tag revista
region America del Norte
libraryname SciELO
language English
format Digital
author Gómez-Almaguer,David
Herrera-Rojas,Miguel
Olivares-Gazca,Juan Carlos
Ruiz-Argüelles,Guillermo J.
spellingShingle Gómez-Almaguer,David
Herrera-Rojas,Miguel
Olivares-Gazca,Juan Carlos
Ruiz-Argüelles,Guillermo J.
Hematopoietic stem cell transplantation (HSCT) in the COVID-19 pandemic era
author_facet Gómez-Almaguer,David
Herrera-Rojas,Miguel
Olivares-Gazca,Juan Carlos
Ruiz-Argüelles,Guillermo J.
author_sort Gómez-Almaguer,David
title Hematopoietic stem cell transplantation (HSCT) in the COVID-19 pandemic era
title_short Hematopoietic stem cell transplantation (HSCT) in the COVID-19 pandemic era
title_full Hematopoietic stem cell transplantation (HSCT) in the COVID-19 pandemic era
title_fullStr Hematopoietic stem cell transplantation (HSCT) in the COVID-19 pandemic era
title_full_unstemmed Hematopoietic stem cell transplantation (HSCT) in the COVID-19 pandemic era
title_sort hematopoietic stem cell transplantation (hsct) in the covid-19 pandemic era
description Abstract The pandemic of coronavirus infectious disease-2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a threat to global health. This has become an obstacle for the practice of hematology, mostly in low-middle income countries. For those hematologist and oncologists who perform hematopoietic stem cell transplantation HSCT the usual challenges of this kind of medical procedures have increased because of the COVID-19 pandemic. The importance of find the best route for performing HSCT avoiding excessive COVID-19 risk is of great importance. By doing so, we have been able to conduct 170 hematopoieic stem cell transplants during the COVID-19 pandemia.
publisher Academia Nacional de Medicina de México A.C.
publishDate 2021
url http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0016-38132021000900020
work_keys_str_mv AT gomezalmaguerdavid hematopoieticstemcelltransplantationhsctinthecovid19pandemicera
AT herrerarojasmiguel hematopoieticstemcelltransplantationhsctinthecovid19pandemicera
AT olivaresgazcajuancarlos hematopoieticstemcelltransplantationhsctinthecovid19pandemicera
AT ruizarguellesguillermoj hematopoieticstemcelltransplantationhsctinthecovid19pandemicera
_version_ 1756219534393475072

Similar Items